{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:42:39Z","timestamp":1787676159521,"version":"build-2784847793"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10741-019-09895-x","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T15:57:18Z","timestamp":1575302238000},"page":"555-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["General principles of heart failure management in adult congenital heart disease"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1566-3697","authenticated-orcid":false,"given":"Rose","family":"Tompkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitra","family":"Romfh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,1]]},"reference":[{"issue":"22","key":"9895_CR1","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.110.946343","volume":"122","author":"P Moons","year":"2010","unstructured":"Moons P et al. (2010) Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 122(22):2264\u20132272","journal-title":"Circulation"},{"issue":"4","key":"9895_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jacc.2005.08.074","volume":"47","author":"RG Williams","year":"2006","unstructured":"Williams RG et al. (2006) Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. J Am Coll Cardiol 47(4):701\u2013707","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"9895_CR3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCULATIONAHA.113.008396","volume":"130","author":"AJ Marelli","year":"2014","unstructured":"Marelli AJ et al. (2014) Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation 130(9):749\u2013756","journal-title":"Circulation"},{"issue":"1","key":"9895_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2005.02.083","volume":"46","author":"CA Warnes","year":"2005","unstructured":"Warnes CA (2005) The adult with congenital heart disease: born to be bad? J Am Coll Cardiol 46(1):1\u20138","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"9895_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijcard.2010.09.015","volume":"154","author":"AC Zomer","year":"2012","unstructured":"Zomer AC et al. (2012) Circumstances of death in adult congenital heart disease. Int J Cardiol 154(2):168\u2013172","journal-title":"Int J Cardiol"},{"issue":"22","key":"9895_CR6","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1161\/CIRCULATIONAHA.115.017202","volume":"132","author":"GP Diller","year":"2015","unstructured":"Diller GP et al. (2015) Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre. Circulation 132(22):2118\u20132125","journal-title":"Circulation"},{"key":"9895_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijcard.2016.02.133","volume":"211","author":"CC Engelings","year":"2016","unstructured":"Engelings CC et al. (2016) Cause of death in adults with congenital heart disease - An analysis of the German National Register for Congenital Heart Defects. Int J Cardiol 211:31\u201336","journal-title":"Int J Cardiol"},{"issue":"5","key":"9895_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11897-016-0301-0","volume":"13","author":"LI Alshawabkeh","year":"2016","unstructured":"Alshawabkeh LI, Opotowsky AR (2016) Burden of Heart Failure in Adults with Congenital Heart Disease. Curr Heart Fail Rep 13(5):247\u2013254","journal-title":"Curr Heart Fail Rep"},{"issue":"Suppl 2","key":"9895_CR9","first-page":"S14","volume":"4","author":"GS Francis","year":"2003","unstructured":"Francis GS, Tang WH (2003) Pathophysiology of congestive heart failure. Rev Cardiovasc Med 4(Suppl 2):S14\u2013S20","journal-title":"Rev Cardiovasc Med"},{"issue":"8","key":"9895_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/CIR.0000000000000352","volume":"133","author":"KK Stout","year":"2016","unstructured":"Stout KK et al. (2016) Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation 133(8):770\u2013801","journal-title":"Circulation"},{"issue":"6","key":"9895_CR11","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.104.529800","volume":"112","author":"GP Diller","year":"2005","unstructured":"Diller GP et al. (2005) Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 112(6):828\u2013835","journal-title":"Circulation"},{"issue":"3","key":"9895_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0002-9149(00)01364-3","volume":"87","author":"PM Fredriksen","year":"2001","unstructured":"Fredriksen PM et al. (2001) Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol 87(3):310\u2013314","journal-title":"Am J Cardiol"},{"issue":"11","key":"9895_CR13","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/eurheartj\/ehr461","volume":"33","author":"A Kempny","year":"2012","unstructured":"Kempny A et al. (2012) Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life--single centre experience and review of published data. Eur Heart J 33(11):1386\u20131396","journal-title":"Eur Heart J"},{"issue":"2","key":"9895_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/CIRCULATIONAHA.111.058719","volume":"125","author":"R Inuzuka","year":"2012","unstructured":"Inuzuka R et al. (2012) Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation 125(2):250\u2013259","journal-title":"Circulation"},{"issue":"10","key":"9895_CR15","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/eurheartj\/ehq032","volume":"31","author":"CL Verheugt","year":"2010","unstructured":"Verheugt CL et al. (2010) Mortality in adult congenital heart disease. Eur Heart J 31(10):1220\u20131229","journal-title":"Eur Heart J"},{"issue":"20","key":"9895_CR16","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1136\/heartjnl-2017-312777","volume":"104","author":"C Yu","year":"2018","unstructured":"Yu C et al. (2018) Causes of death in a contemporary adult congenital heart disease cohort. Heart 104(20):1678\u20131682","journal-title":"Heart"},{"issue":"6","key":"9895_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/chd.12019","volume":"8","author":"FH Rodriguez 3rd","year":"2013","unstructured":"Rodriguez FH 3rd et al. (2013) Outcomes of heart failure-related hospitalization in adults with congenital heart disease in the United States. Congenit Heart Dis 8(6):513\u2013519","journal-title":"Congenit Heart Dis"},{"issue":"3","key":"9895_CR18","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/j.ijcard.2013.03.003","volume":"168","author":"AC Zomer","year":"2013","unstructured":"Zomer AC et al. (2013) Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol 168(3):2487\u20132493","journal-title":"Int J Cardiol"},{"issue":"5","key":"9895_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.acvd.2017.01.008","volume":"110","author":"NB Moussa","year":"2017","unstructured":"Moussa NB et al. (2017) Characteristics and outcomes of heart failure-related hospitalization in adults with congenital heart disease. Arch Cardiovasc Dis 110(5):283\u2013291","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"9895_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ejhf.1051","volume":"20","author":"S Lal","year":"2018","unstructured":"Lal S et al. (2018) Heart failure admissions and poor subsequent outcomes in adults with congenital heart disease. Eur J Heart Fail 20(4):812\u2013815","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"9895_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cardfail.2010.04.005","volume":"16","author":"Heart Failure Society of, A","year":"2010","unstructured":"Heart Failure Society of, A (2010) Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 16(6):475\u2013539","journal-title":"J Card Fail"},{"key":"9895_CR22","doi-asserted-by":"crossref","unstructured":"Wang F et al. (2019) Heart failure risk predictions in adult patients with congenital heart disease: a systematic review. Heart 105(21):1661\u20131669","DOI":"10.1136\/heartjnl-2019-314977"},{"issue":"24","key":"9895_CR23","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1161\/CIRCULATIONAHA.105.594218","volume":"113","author":"K Dimopoulos","year":"2006","unstructured":"Dimopoulos K et al. (2006) Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation 113(24):2796\u20132802","journal-title":"Circulation"},{"key":"9895_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ijcard.2015.05.174","volume":"196","author":"J Muller","year":"2015","unstructured":"Muller J et al. (2015) Peak oxygen uptake, ventilatory efficiency and QRS-duration predict event free survival in patients late after surgical repair of tetralogy of Fallot. Int J Cardiol 196:158\u2013164","journal-title":"Int J Cardiol"},{"issue":"21","key":"9895_CR25","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.jacc.2012.02.092","volume":"60","author":"JA Eindhoven","year":"2012","unstructured":"Eindhoven JA et al. (2012) The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J Am Coll Cardiol 60(21):2140\u20132149","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"9895_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1161\/CIRCULATIONAHA.116.023255","volume":"135","author":"VJ Baggen","year":"2017","unstructured":"Baggen VJ et al. (2017) Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease. Circulation 135(3):264\u2013279","journal-title":"Circulation"},{"issue":"2","key":"9895_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/hrt.81.2.182","volume":"81","author":"D Sanchez-Quintana","year":"1999","unstructured":"Sanchez-Quintana D et al. (1999) Myoarchitecture and connective tissue in hearts with tricuspid atresia. Heart 81(2):182\u2013191","journal-title":"Heart"},{"issue":"3","key":"9895_CR28","doi-asserted-by":"publisher","first-page":"H959","DOI":"10.1152\/ajpheart.2000.279.3.H959","volume":"279","author":"K Tobita","year":"2000","unstructured":"Tobita K, Keller BB (2000) Right and left ventricular wall deformation patterns in normal and left heart hypoplasia chick embryos. Am J Physiol Heart Circ Physiol 279(3):H959\u2013H969","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"9895_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semcdb.2007.01.001","volume":"18","author":"BL Black","year":"2007","unstructured":"Black BL (2007) Transcriptional pathways in second heart field development. Semin Cell Dev Biol 18(1):67\u201376","journal-title":"Semin Cell Dev Biol"},{"issue":"13","key":"9895_CR30","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1136\/hrt.2009.191718","volume":"96","author":"T Rutz","year":"2010","unstructured":"Rutz T et al. (2010) Right ventricular absolute myocardial blood flow in complex congenital heart disease. Heart 96(13):1056\u20131062","journal-title":"Heart"},{"issue":"4","key":"9895_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0735-1097(00)00864-0","volume":"36","author":"B Lubiszewska","year":"2000","unstructured":"Lubiszewska B et al. (2000) Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up. J Am Coll Cardiol 36(4):1365\u20131370","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"9895_CR32","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1136\/heart.89.10.1231","volume":"89","author":"M Hauser","year":"2003","unstructured":"Hauser M et al. (2003) Impaired myocardial blood flow and coronary flow reserve of the anatomical right systemic ventricle in patients with congenitally corrected transposition of the great arteries. Heart 89(10):1231\u20131235","journal-title":"Heart"},{"issue":"4","key":"9895_CR33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s00246-002-0355-5","volume":"24","author":"M Hauser","year":"2003","unstructured":"Hauser M et al. (2003) Myocardial perfusion and coronary flow reserve assessed by positron emission tomography in patients after Fontan-like operations. Pediatr Cardiol 24(4):386\u2013392","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"9895_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/01.CIR.0000020009.30736.3F","volume":"106","author":"AP Bolger","year":"2002","unstructured":"Bolger AP et al. (2002) Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106(1):92\u201399","journal-title":"Circulation"},{"issue":"14","key":"9895_CR35","first-page":"e698","volume":"139","author":"KK Stout","year":"2019","unstructured":"Stout KK et al. (2019) 2018 AHA\/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139(14):e698\u2013e800","journal-title":"Circulation"},{"issue":"2","key":"9895_CR36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ehf2.12225","volume":"5","author":"G Cattadori","year":"2018","unstructured":"Cattadori G et al. (2018) Exercise and heart failure: an update. ESC Heart Fail 5(2):222\u2013232","journal-title":"ESC Heart Fail"},{"issue":"6","key":"9895_CR37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ehf2.12387","volume":"5","author":"T Suzuki","year":"2018","unstructured":"Suzuki T, Palus S, Springer J (2018) Skeletal muscle wasting in chronic heart failure. ESC Heart Fail 5(6):1099\u20131107","journal-title":"ESC Heart Fail"},{"issue":"2","key":"9895_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10741-016-9592-1","volume":"22","author":"DL Brunjes","year":"2017","unstructured":"Brunjes DL, Kennel PJ, Christian Schulze P (2017) Exercise capacity, physical activity, and morbidity. Heart Fail Rev 22(2):133\u2013139","journal-title":"Heart Fail Rev"},{"issue":"1","key":"9895_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/CIRCHEARTFAILURE.113.001420","volume":"8","author":"JL Fleg","year":"2015","unstructured":"Fleg JL et al. (2015) Exercise training as therapy for heart failure: current status and future directions. Circ Heart Fail 8(1):209\u2013220","journal-title":"Circ Heart Fail"},{"issue":"1","key":"9895_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/chd.12555","volume":"13","author":"Y Shiina","year":"2018","unstructured":"Shiina Y et al. (2018) Body composition, appetite-related hormones, adipocytokines, and heart failure in adult patients with congenital heart disease: A preliminary study. Congenit Heart Dis 13(1):79\u201384","journal-title":"Congenit Heart Dis"},{"issue":"6","key":"9895_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/14779072.2018.1471356","volume":"16","author":"JQ Hooglugt","year":"2018","unstructured":"Hooglugt JQ et al. (2018) The effect of exercise training in symptomatic patients with grown-up congenital heart disease: a review. Expert Rev Cardiovasc Ther 16(6):379\u2013386","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"9895_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/HCO.0000000000000582","volume":"34","author":"R Cordina","year":"2019","unstructured":"Cordina R, d'Udekem Y (2019) Long-lasting benefits of exercise for those living with a Fontan circulation. Curr Opin Cardiol 34(1):79\u201386","journal-title":"Curr Opin Cardiol"},{"issue":"3","key":"9895_CR43","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.athoracsur.2014.09.086","volume":"99","author":"JW Cramer","year":"2015","unstructured":"Cramer JW et al. (2015) Tricuspid repair at pulmonary valve replacement does not alter outcomes in tetralogy of Fallot. Ann Thorac Surg 99(3):899\u2013904","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"9895_CR44","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.athoracsur.2015.01.062","volume":"99","author":"B Kogon","year":"2015","unstructured":"Kogon B et al. (2015) Leaving Moderate Tricuspid Valve Regurgitation Alone at the Time of Pulmonary Valve Replacement: A Worthwhile Approach. Ann Thorac Surg 99(6):2117\u20132122 discussion 2122-3","journal-title":"Ann Thorac Surg"},{"issue":"14","key":"9895_CR45","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jacc.2016.07.734","volume":"68","author":"TK Jones","year":"2016","unstructured":"Jones TK et al. (2016) Transcatheter Pulmonary Valve Replacement Reduces Tricuspid Regurgitation in Patients With Right Ventricular Volume\/Pressure Overload. J Am Coll Cardiol 68(14):1525\u20131535","journal-title":"J Am Coll Cardiol"},{"key":"9895_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijcard.2017.05.122","volume":"243","author":"OI Woudstra","year":"2017","unstructured":"Woudstra OI et al. (2017) Clinical course of tricuspid regurgitation in repaired tetralogy of Fallot. Int J Cardiol 243:191\u2013193","journal-title":"Int J Cardiol"},{"issue":"1","key":"9895_CR47","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jtcvs.2016.12.062","volume":"154","author":"F Roubertie","year":"2017","unstructured":"Roubertie F et al. (2017) Tricuspid valve repair and pulmonary valve replacement in adults with repaired tetralogy of Fallot. J Thorac Cardiovasc Surg 154(1):214\u2013223","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"20","key":"9895_CR48","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","volume":"137","author":"MA Konstam","year":"2018","unstructured":"Konstam MA et al. (2018) Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation 137(20):e578\u2013e622","journal-title":"Circulation"},{"issue":"3","key":"9895_CR49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijcard.2010.09.057","volume":"154","author":"SV Babu-Narayan","year":"2012","unstructured":"Babu-Narayan SV et al. (2012) Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). Int J Cardiol 154(3):299\u2013305","journal-title":"Int J Cardiol"},{"issue":"14","key":"9895_CR50","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.117.031438","volume":"137","author":"JP Bokma","year":"2018","unstructured":"Bokma JP et al. (2018) Effect of Losartan on Right Ventricular Dysfunction: Results From the Double-Blind, Randomized REDEFINE Trial (Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-Angiotensin-Aldosterone System) in Adults With Repaired Tetralogy of Fallot. Circulation 137(14):1463\u20131471","journal-title":"Circulation"},{"issue":"8","key":"9895_CR51","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.amjcard.2010.12.026","volume":"107","author":"CS Broberg","year":"2011","unstructured":"Broberg CS et al. (2011) Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of fallot. Am J Cardiol 107(8):1215\u20131220","journal-title":"Am J Cardiol"},{"issue":"9","key":"9895_CR52","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0735-1097(02)02344-6","volume":"40","author":"A Ghai","year":"2002","unstructured":"Ghai A et al. (2002) Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol 40(9):1675\u20131680","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"9895_CR53","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/ehjci\/jet260","volume":"15","author":"A Dragulescu","year":"2014","unstructured":"Dragulescu A, Friedberg MK (2014) A tale of two ventricles: ventricular-ventricular interactions and LV dysfunction after surgical repair of Tetralogy of Fallot. Eur Heart J Cardiovasc Imaging 15(5):498\u2013499","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"9895_CR54","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijcard.2018.07.132","volume":"272","author":"S Krupickova","year":"2018","unstructured":"Krupickova S et al. (2018) Ramipril and left ventricular diastolic function in stable patients with pulmonary regurgitation after repair of tetralogy of Fallot. Int J Cardiol 272:64\u201369","journal-title":"Int J Cardiol"},{"issue":"11","key":"9895_CR55","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/S0735-1097(02)02566-4","volume":"40","author":"PA Davlouros","year":"2002","unstructured":"Davlouros PA et al. (2002) Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol 40(11):2044\u20132052","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"9895_CR56","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.amjcard.2006.10.025","volume":"99","author":"AR Doughan","year":"2007","unstructured":"Doughan AR, McConnell ME, Book WM (2007) Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol 99(5):704\u2013706","journal-title":"Am J Cardiol"},{"issue":"2","key":"9895_CR57","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijcard.2006.01.048","volume":"114","author":"A Giardini","year":"2007","unstructured":"Giardini A et al. (2007) A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle. Int J Cardiol 114(2):241\u2013246","journal-title":"Int J Cardiol"},{"issue":"6","key":"9895_CR58","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1017\/S1047951110000764","volume":"20","author":"R Bouallal","year":"2010","unstructured":"Bouallal R et al. (2010) Interest of beta-blockers in patients with right ventricular systemic dysfunction. Cardiol Young 20(6):615\u2013619","journal-title":"Cardiol Young"},{"issue":"14","key":"9895_CR59","doi-asserted-by":"publisher","first-page":"e801","DOI":"10.1161\/CIR.0000000000000604","volume":"139","author":"E Zaragoza-Macias","year":"2019","unstructured":"Zaragoza-Macias E et al. (2019) Medical Therapy for Systemic Right Ventricles: A Systematic Review (Part 1) for the 2018 AHA\/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139(14):e801\u2013e813","journal-title":"Circulation"},{"issue":"4","key":"9895_CR60","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/CIRCEP.108.776120","volume":"1","author":"P Khairy","year":"2008","unstructured":"Khairy P et al. (2008) Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol 1(4):250\u2013257","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"9895_CR61","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.112.135392","volume":"127","author":"T van der Bom","year":"2013","unstructured":"van der Bom T et al. (2013) Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation 127(3):322\u2013330","journal-title":"Circulation"},{"key":"9895_CR62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijcard.2018.11.027","volume":"278","author":"AC van Dissel","year":"2019","unstructured":"van Dissel AC et al. (2019) Long-term clinical outcomes of valsartan in patients with a systemic right ventricle: Follow-up of a multicenter randomized controlled trial. Int J Cardiol 278:84\u201387","journal-title":"Int J Cardiol"},{"key":"9895_CR63","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ijcard.2017.05.079","volume":"243","author":"D Tobler","year":"2017","unstructured":"Tobler D et al. (2017) Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function - A multi-center, double-blind, randomized, placebo-controlled clinical trial - SERVE trial - Rational and design. Int J Cardiol 243:354\u2013359","journal-title":"Int J Cardiol"},{"issue":"8","key":"9895_CR64","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"CW Yancy","year":"2017","unstructured":"Yancy CW et al. (2017) 2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail 23(8):628\u2013651","journal-title":"J Card Fail"},{"key":"9895_CR65","doi-asserted-by":"publisher","unstructured":"Appadurai V et al. (2018) Sacubitril\/Valsartan in Adult Congenital Heart Disease Patients With Chronic Heart Failure - A Single Centre Case Series and Call for an International Registry. Heart Lung Circ https:\/\/doi.org\/10.1016\/j.hlc.2018.12.003","DOI":"10.1016\/j.hlc.2018.12.003"},{"issue":"4","key":"9895_CR66","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/chd.12368","volume":"11","author":"WM Book","year":"2016","unstructured":"Book WM et al. (2016) Clinical Phenotypes of Fontan Failure: Implications for Management. Congenit Heart Dis 11(4):296\u2013308","journal-title":"Congenit Heart Dis"},{"issue":"6","key":"9895_CR67","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1253\/circj.CJ-10-0845","volume":"75","author":"N Ishibashi","year":"2011","unstructured":"Ishibashi N et al. (2011) Effect of Carvedilol on Heart Failure in Patients With a Functionally Univentricular Heart. Circ J 75(6):1394\u20131399","journal-title":"Circ J"},{"issue":"5","key":"9895_CR68","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1161\/01.CIR.96.5.1507","volume":"96","author":"AA Kouatli","year":"1997","unstructured":"Kouatli AA et al. (1997) Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation 96(5):1507\u20131512","journal-title":"Circulation"},{"issue":"1","key":"9895_CR69","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1747-0803.2008.00240.x","volume":"4","author":"WT Mahle","year":"2009","unstructured":"Mahle WT et al. (2009) Impact of spironolactone on endothelial function in patients with single ventricle heart. Congenit Heart Dis 4(1):12\u201316","journal-title":"Congenit Heart Dis"},{"key":"9895_CR70","doi-asserted-by":"crossref","unstructured":"Saiki H, Eidem BW, Ohtani T, Grogan MA, Redfield MM (2016) Ventricular-Arterial Function and Coupling in the Adult Fontan Circulation. J Am Heart Assoc 5(9):e003887","DOI":"10.1161\/JAHA.116.003887"},{"issue":"1","key":"9895_CR71","doi-asserted-by":"crossref","first-page":"204589401879045","DOI":"10.1177\/2045894018790450","volume":"9","author":"W Wang","year":"2019","unstructured":"Wang W, Hu X, Liao W, Rutahoile WH, Malenka DJ, Zeng X, Yang Y, Feng P, Wen L, Huang W (2019) The efficacy and safety of pulmonary vasodilators in patients with Fontan circulation: a meta-analysis of randomized controlled trials. Pulm Circ 9(1):2045894018790450","journal-title":"Pulm Circ"},{"issue":"21","key":"9895_CR72","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/heartjnl-2015-307930","volume":"101","author":"T Alsaied","year":"2015","unstructured":"Alsaied T et al. (2015) Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis. Heart 101(21):1731\u20131737","journal-title":"Heart"},{"issue":"3","key":"9895_CR73","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jjcc.2016.04.001","volume":"68","author":"H Ohuchi","year":"2016","unstructured":"Ohuchi H (2016) Adult patients with Fontan circulation: What we know and how to manage adults with Fontan circulation? J Cardiol 68(3):181\u2013189","journal-title":"J Cardiol"},{"issue":"10","key":"9895_CR74","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/j.hrthm.2014.05.009","volume":"11","author":"P Khairy","year":"2014","unstructured":"Khairy P et al. (2014) PACES\/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 11(10):e102\u2013e165","journal-title":"Heart Rhythm"},{"issue":"2","key":"9895_CR75","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ccep.2017.02.011","volume":"9","author":"T Contractor","year":"2017","unstructured":"Contractor T, Levin V, Mandapati R (2017) Drug Therapy in Adult Congenital Heart Disease. Card Electrophysiol Clin 9(2):295\u2013309","journal-title":"Card Electrophysiol Clin"},{"issue":"2","key":"9895_CR76","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/chd.12695","volume":"14","author":"M Lewis","year":"2019","unstructured":"Lewis M et al. (2019) Predictors and rates of recurrence of atrial arrhythmias following catheter ablation in adults with congenital heart disease. Congenit Heart Dis 14(2):207\u2013212","journal-title":"Congenit Heart Dis"},{"issue":"6","key":"9895_CR77","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/01.CIR.67.6.1374","volume":"67","author":"JC Huhta","year":"1983","unstructured":"Huhta JC et al. (1983) Complete atrioventricular block in patients with atrioventricular discordance. Circulation 67(6):1374\u20131377","journal-title":"Circulation"},{"issue":"16","key":"9895_CR78","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW et al. (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62(16):e147\u2013e239","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"9895_CR79","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11886-018-1015-6","volume":"20","author":"S Anjewierden","year":"2018","unstructured":"Anjewierden S, Aziz PF (2018) Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time? Curr Cardiol Rep 20(9):75","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"9895_CR80","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1253\/circj.CJ-14-0395","volume":"79","author":"H Sakaguchi","year":"2015","unstructured":"Sakaguchi H et al. (2015) Cardiac resynchronization therapy for various systemic ventricular morphologies in patients with congenital heart disease. Circ J 79(3):649\u2013655","journal-title":"Circ J"},{"issue":"2","key":"9895_CR81","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/europace\/euw386","volume":"20","author":"Z Koyak","year":"2018","unstructured":"Koyak Z et al. (2018) Cardiac resynchronization therapy in adults with congenital heart disease. Europace 20(2):315\u2013322","journal-title":"Europace"},{"issue":"3","key":"9895_CR82","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/CIRCULATIONAHA.107.726372","volume":"117","author":"P Khairy","year":"2008","unstructured":"Khairy P et al. (2008) Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation 117(3):363\u2013370","journal-title":"Circulation"},{"issue":"10","key":"9895_CR83","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/pace.12933","volume":"39","author":"D Backhoff","year":"2016","unstructured":"Backhoff D et al. (2016) Internal Cardioverter Defibrillator Indications and Therapies after Atrial Baffle Procedure for d-Transposition of the Great Arteries: A Multicenter Analysis. Pacing Clin Electrophysiol 39(10):1070\u20131076","journal-title":"Pacing Clin Electrophysiol"},{"key":"9895_CR84","doi-asserted-by":"crossref","unstructured":"Moore JP et al. (2016) Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease. Circ Arrhythm Electrophysiol 9:e004338","DOI":"10.1161\/CIRCEP.116.004338"},{"key":"9895_CR85","doi-asserted-by":"crossref","unstructured":"Vehmeijer JT et al. (2019) PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design. Neth Heart J 27(10):474-479","DOI":"10.1007\/s12471-019-1297-3"},{"issue":"8","key":"9895_CR86","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/CIR.0000000000000353","volume":"133","author":"HJ Ross","year":"2016","unstructured":"Ross HJ et al. (2016) Transplantation and Mechanical Circulatory Support in Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation 133(8):802\u2013820","journal-title":"Circulation"},{"issue":"10","key":"9895_CR87","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.healun.2018.07.022","volume":"37","author":"KK Khush","year":"2018","unstructured":"Khush KK et al. (2018) The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant 37(10):1155\u20131168","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"9895_CR88","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.healun.2010.09.008","volume":"30","author":"MD Everitt","year":"2011","unstructured":"Everitt MD et al. (2011) Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant 30(4):395\u2013401","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"9895_CR89","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.healun.2014.05.001","volume":"33","author":"SW Goldberg","year":"2014","unstructured":"Goldberg SW et al. (2014) Adults with congenital heart disease and heart transplantation: optimizing outcomes. J Heart Lung Transplant 33(9):873\u2013877","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"9895_CR90","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.healun.2014.05.007","volume":"33","author":"LJ Burchill","year":"2014","unstructured":"Burchill LJ et al. (2014) Impact of adult congenital heart disease on survival and mortality after heart transplantation. J Heart Lung Transplant 33(11):1157\u20131163","journal-title":"J Heart Lung Transplant"},{"issue":"3-4","key":"9895_CR91","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pcad.2018.09.004","volume":"61","author":"M Lewis","year":"2018","unstructured":"Lewis M, Rosenbaum M (2018) When Should Adult Congenital Heart Disease Patients be Considered for Transplant and Deciding Which Organs to Transplant. Prog Cardiovasc Dis 61(3-4):377\u2013381","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"9895_CR92","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.healun.2017.11.010","volume":"37","author":"A Cedars","year":"2018","unstructured":"Cedars A et al. (2018) An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. J Heart Lung Transplant 37(5):619\u2013630","journal-title":"J Heart Lung Transplant"},{"key":"9895_CR93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijcard.2017.07.107","volume":"245","author":"JM Steiner","year":"2017","unstructured":"Steiner JM et al. (2017) Durable mechanical circulatory support in teenagers and adults with congenital heart disease: A systematic review. Int J Cardiol 245:135\u2013140","journal-title":"Int J Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09895-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:54:08Z","timestamp":1695480848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09895-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["9895"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09895-x","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,1]]},"assertion":[{"value":"1 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The manuscript is a review of the literature and does not contain original clinical study or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Drs. Rose Tompkins and Anitra Romfh have no conflicts of interest or financial ties to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}